Enliven Therapeutics, Inc. (ELVN)

Healthcare · Biotechnology · NASDAQ

Enliven Therapeutics, Inc. (ELVN) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $3.53B and a free-cash-flow yield of -2.6%.

Market cap	$3.53B
Trailing P/E	—
FCF yield	-2.6%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ELVN data on Nama Insights →